Trial intelligence / Profile preview

Effectiveness and safety of direct acting antivirals for chronic hepatitis C in Thailand

TCTR20200313005Enrolling by invitation

Start
Aug 2017
Countries
1
01

Overview

Open-label trial in chronic hepatitis C (CHC), sponsored by None. Started Aug 2017; status: enrolling by invitation.

02

Conditions

chronic hepatitis C (CHC)

Beyond the preview

Go deeper on TCTR20200313005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200313005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call